Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 7, 2002, Pages 387-394

  MacMillan, Margaret L ^a   Weisdorf, Daniel J ^a   Wagner, John E ^a   DeFor, Todd E ^a   Burns, Linda J ^a   Ramsay, Norma K C ^a   Davies, Stella M ^a   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acute GVHD; GVHD grading systems; Hematopoietic stem cell transplantation; Primary therapy; Steroids

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; HYDROCORTISONE; METHOTREXATE; METHYLPREDNISOLONE; NYSTATIN; PENICILLIN V POTASSIUM; PREDNISONE; STEROID; TACROLIMUS; TRIAMCINOLONE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL TRACT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INFANT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOSIS; OUTCOMES RESEARCH; PNEUMOCYSTIS PNEUMONIA; PROBABILITY; RECIPIENT; REGISTRATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SIBLING; SURVIVAL; T LYMPHOCYTE;

EID: 0036048349     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm12171485     Document Type: Article

References (23)

1. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment
2. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome
3. Acute upper gastrointestinal graft-versus-host disease: Clinical significance and response to immunosuppressive therapy
4. Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy
5. Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation
6. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
7. 1994 Consensus Conference on Acute GVHD Grading
8. IBMTR severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade
9. Unrelated donor bone marrow transplantation for children with acute leukemia
10. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program
11. Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia
12. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation
13. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia
14. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission
15. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: Results of a matched-pair analysis
16. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
17. Prednisone therapy for acute graft-versus-host disease: Short-versus long-term treatment: A prospective randomized trial
18. Nonparametric estimation from incomplete observations
19. Applied Survival Analysis
20. Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
21. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors